Repligen (RGEN) Tops Q2 EPS by 15c, Revenues Beat; Raises FY20 EPS/Revenue Guidance Above Consensus

Go back to Repligen (RGEN) Tops Q2 EPS by 15c, Revenues Beat; Raises FY20 EPS/Revenue Guidance Above Consensus
Repligen Corp (NASDAQ: RGEN) Delayed: 132.02 -1.53 (1.15%)
Previous Close $133.55    52 Week High $33.79 
Open $131.40    52 Week Low $20.07 
Day High $133.57    P/E 188.60 
Day Low $127.48    EPS $0.70 
Volume 1,236,920